NCT02592876 2019-05-17
Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma
Seagen Inc.
Phase 2 Terminated
Seagen Inc.
Seagen Inc.
Swedish Orphan Biovitrum
Otsuka Pharmaceutical Development & Commercialization, Inc.
Texas Oncology Cancer Center